A Comparative Study of Pre-operative Oral Clonidine and Pregabalin on Post-operative Analgesia After Spinal Anesthesia
Overview
Affiliations
Objectives: Pregabalin and clonidine have anti-nociceptive properties. This study assesses their efficacy in prolonging the analgesic effect of spinal anesthesia and post-operative analgesic requirement in patients undergoing vaginal hysterectomy.
Materials And Methods: A total of 90 females in the age group of 30-60 years were randomly allocated in to three groups of 30 each, to receive either oral clonidine (150 μg) or oral pregabalin (150 mg) or oral multivitamin as placebo 1.5 h before spinal anesthesia with 3ml (15 mg) of 0.5% hyperbaric bupivacaine. Intensity of pain was measured on a visual analog scale (VAS) at the end of operation (0 h) then at 1,2,4,6,12 and 24 h thereafter. Diclofenac sodium intramuscularly 1 mg/kg was provided when the VASscore was >4 in the study period. Sedation was defined by Ramsay sedation scale at 0,6,12 and 24 h. Side-effects such as nausea and vomiting, respiratory depression and dryness of mouth were noted.
Results: The VAS scores were significantly less in the pregabalin group compared with the clonidine group at 6,12 and 24 h post-operatively with a P < 0.0001. More sedation was seen in the clonidine group than in the pregabalin group (P < 0.05). Analgesic consumption and VAS scores were lower in clonidine and pregabalin group compared with the placebo group (P < 0.05).
Conclusion: Oral pregabalin (150 mg) prolongs the post-operative pain relief after spinal anesthesia but produces less sedation compared with oral clonidine (150 μg).
Abu-Zaid A, Alomar O, AlNaim N, AbuAlsaud F, Jamjoom M, AlNaim L Obstet Gynecol Sci. 2022; 65(2):133-144.
PMID: 35193327 PMC: 8942753. DOI: 10.5468/ogs.21345.
Mishra S, Gogia P, Singh P, Tripathi M, Yadav S, Malviya D Anesth Essays Res. 2021; 15(1):81-86.
PMID: 34667353 PMC: 8462434. DOI: 10.4103/aer.aer_84_21.
Bala R, Kaur J, Sharma J, Singh R Asian Spine J. 2019; 13(6):967-975.
PMID: 31352721 PMC: 6894979. DOI: 10.31616/asj.2019.0031.
Hu J, Huang D, Li M, Wu C, Zhang J J Pain Res. 2018; 11:2633-2643.
PMID: 30519075 PMC: 6233947. DOI: 10.2147/JPR.S170810.
Rahat Dahmardeh A, Moosavi A, Nasir-Al-Din Tabatabaei S, Ordoni Avval J, Sistanizad M Iran J Pharm Res. 2018; 17(Suppl):2-7.
PMID: 29796024 PMC: 5958319.